SHS Capital is a Tübingen-based private equity and growth investor specialising in healthcare. It invests in established companies and scale-ups across medical technology, pharmaceuticals, diagnostics and health technology, primarily in the DACH region, the Nordics and the Benelux. SHS takes minority and majority stakes and supports market access, reimbursement, commercialisation, acquisitions and international expansion. Its healthcare portfolio includes AI-assisted epilepsy monitoring, migraine neuromodulation and robotic rehabilitation.
Founded
1993
Type
Venture capital
Funds1
SHS VII Healthcare Investments—
Healthcare private equity and growth fund legally formed in March2026, confirmed by the GLEIF legal-entity record. The April16,2026 date is the manager’s Key Information Document date, not a claimed fundraising launch or close. The fund invests in lower-middle-market healthcare companies, primarily in DACH, Benelux and Nordic countries, across medical technology and suppliers, pharma and suppliers, diagnostics and tools, and health technology. Fundraising target and closed amount are undisclosed in the reviewed primary document.